Skip to main content

The transcriptional cascade associated with creatine kinase down-regulation and mitochondrial biogenesis in mice sarcoma

Abstract

The tissue-specific expressions of creatine kinase (CK) isoforms are regulated by the coordinated action of various transcription factors. The myogenic differentiation factor D (MyoD) family of proteins and the myocyte-specific enhancer binding factor 2 family of transcription factors are important in regulating the muscle-specific expression of cytosolic muscle-type CK (MCK) and mitochondrial CKs. As reported in some related studies, TNF-α mediated degradation of MyoD and myogenin mRNA may lead to severe muscle wasting and cachexia, which is characterized by a low transcript level of MCK and myosin heavy chain proteins. In our previous study, we reported on a complete loss of total CK activity and expression when sarcoma was induced in mouse skeletal muscle (Patra et al. FEBS J. 275 (2008) 3236–3247). This study aimed at investigating the transcriptional cascade of CK down-regulation in carcinogen-induced sarcoma in mouse muscle. Both CK deficiency and enhanced nitric oxide synthase (NOS) were known to augment mitochondrial biogenesis, so we also explored the activation of the transcriptional cascade of mitochondrial biogenesis in this cancer. We observed the activation of the TNF-α-mediated nitric oxide production pathway with NFκB activation and concomitant degradation of MyoD and myogenin mRNA. Exploration of mitochondrial biogenesis revealed high cytochrome c oxidase activity and mitochondrial DNA content in sarcoma. The PGC-related co-activator seems to have a major role in regulating mitochondrial biogenesis by upregulating nuclear respiratory factors and mitochondrial transcription factor A. From the above findings, it can be concluded that severe muscle degeneration leads to CK down-regulation in sarcoma, and that the stimulation of mitochondrial biogenesis indicated a scenario representing both CK deficiency and NOS overexpression on the one hand, and altered bioenergetic profiling on the other.

Abbreviations

CK:

creatine kinase

COX:

cytochrome c oxidase

CS:

citrate synthase

eNOS:

endothelial nitric oxide synthase

iNOS:

inducible nitric oxide synthase

MCK:

muscle-type CK

Mef2:

myocyte-specific enhancer binding factor 2

mtTFA:

mitochondrial transcription factor A

MyHC:

myosin heavy chain

MyoD:

myogenic differentiation factor D

NM:

normal muscle

NOS:

nitric oxide synthase

NRF:

nuclear respiratory factor

PGC:

peroxisome proliferator-activated receptor gamma co-activator

PRC:

PGC-related co-activator

sMitCK:

sarcomeric mitochondrial CK

ST:

sarcoma tissue

TNF-α:

tumor necrosis factor α

References

  1. Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K. and Eppenberger, H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem. J. 281 (1992) 21–40.

    PubMed  CAS  Google Scholar 

  2. Qin, W., Khuchua, Z., Cheng, J., Boero, J., Payne, R.M. and Strauss, A.W. Molecular characterization of the creatine kinases and some historical perspectives. Mol. Cell Biochem. 184 (1998) 153–167.

    PubMed  Article  CAS  Google Scholar 

  3. Edmondson, D.G. and Olson, E.N. Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem. 268 (1993) 755–758.

    PubMed  CAS  Google Scholar 

  4. Martin, J.F., Schwarz, J.J. and Olson, E.N. Myocyte enhancer factor (MEF) 2C: A tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. 90 (1993) 5282–5286.

    PubMed  Article  CAS  Google Scholar 

  5. Buskin, J.N. and Hauschka, S.D. Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell Biol. 9 (1989) 2627–2640.

    PubMed  CAS  Google Scholar 

  6. MoIkentin, J.D., Black, B.L., Martin, J.F. and Olson, E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83 (1995) 1125–1136.

    Article  Google Scholar 

  7. Patra, S., Bera, S., Roy, S.S., Ghoshal, S., Ray, S., Basu, A., Schlattner, U., Wallimann, T. and Ray, M. Progressive decrease of phospho-creatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma. FEBS J. 275 (2008) 3236–3247.

    PubMed  Article  CAS  Google Scholar 

  8. Langen, R.C., Van Der Velden, J.L., Schols, A.M., Kelders, M.C., Wouters, E.F. and Janssen-Heininger, Y.M. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 18 (2004) 227–237.

    PubMed  Article  CAS  Google Scholar 

  9. Guttridge, D.C., Mayo, M.W., Madrid, L.V., Wang, C.Y. and Baldwin, A.S. Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289 (2000) 2363–2366.

    PubMed  Article  CAS  Google Scholar 

  10. Williams, G., Brown, T., Becker, L., Prager, M. and Giroir, B.P. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am. J. Physiol. 267 (1994) R1020–R1025.

    PubMed  CAS  Google Scholar 

  11. Di Marco, S., Mazroui, R., Dallaire, P., Chittur, S., Tenenbaum, S.A., Radzioch, D., Marette, A. and Gallouzi, I.E. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol. Cell Biol. 25 (2005) 6533–6545.

    PubMed  Article  Google Scholar 

  12. Broussard, S.R., McCusker, R.H., Novakofski, J.E., Strle, K., Shen, W.H., Johnson, R.W., Freund, G.G., Dantzer, R. and Kelley, K.W. Cytokine-hormone interactions: tumor necrosis factor-α impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology 144 (2003) 2988–2996.

    PubMed  Article  CAS  Google Scholar 

  13. Vaarmann, A., Fortin, D., Veksler, V., Momken, I., Ventura-Clapier, R. and Garnier, A. Mitochondrial biogenesis in fast skeletal muscle of CK deficient mice. Biochim. Biophys. Acta 1777 (2008) 39–47.

    PubMed  Article  CAS  Google Scholar 

  14. Scarpulla, R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88 (2008) 611–638.

    PubMed  Article  CAS  Google Scholar 

  15. Scarpulla, R.C. Nuclear control of respiratory chain expression in mammalian cells. J. Bioenerg. Biomembr. 29 (1997) 109–119.

    PubMed  Article  CAS  Google Scholar 

  16. Moyes, C.D., Mathieu-costello, O.A., Tsuchiya, N., Filburn, C. and Hansford, R.G. Mitochondrial biogenesis during cellular differentiation. Am. J. Physiol. 272 (1997) Cl345–Cl351.

    Google Scholar 

  17. Leek, B.T., Mudaliar, S.R.D., Henry, R., Mathieu-costello, O.A. and Richardson, R.S. Effect of acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R441–R447.

    PubMed  CAS  Google Scholar 

  18. Cox, B. and Emili, A. Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat. Protoc. 1 (2006) 1872–1878.

    PubMed  Article  CAS  Google Scholar 

  19. Layne, E. Sepctrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol. 3 (1957) 447–454.

    Article  Google Scholar 

  20. Ross, J.A. and Nesnow, S. Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat. Res. 424 (1999) 155–166.

    PubMed  CAS  Google Scholar 

  21. Kuru, S., Inukai, A., Kato, T., Liang, Y., Kimura, S. and Sobue, G. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and noninflammatory myopathies. Acta Neuropathol. 105 (2003) 217–224.

    PubMed  CAS  Google Scholar 

  22. Florini, J.R., Ewton, D.Z. and Coolican, S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17 (1996) 481–517.

    PubMed  CAS  Google Scholar 

  23. Yu, H. and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92 (2000) 1472–1489.

    PubMed  Article  CAS  Google Scholar 

  24. Frost, R.A., Nystrom, G.J. and Lang, C.H. Tumor necrosis factor-α decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology 144 (2003) 1770–1779.

    PubMed  Article  CAS  Google Scholar 

  25. Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S. and Carruba, M.O. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299 (2003) 896–899.

    PubMed  Article  CAS  Google Scholar 

  26. Savagner, F., Mirebeau, D., Jacques, C., Guyetant, S., Morgan, C., Franc, B., Reynier, P. and Malthièry, Y. PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. Biochem. Biophys. Res. Commun. 310 (2003) 779–784.

    PubMed  Article  CAS  Google Scholar 

  27. Dong, X., Ghoshal, K., Majumder, S., Yadav, S.P. and Jacob, S.T. Mitochondrial transcription factor A and its downstream targets are upregulated in a rat hepatoma. J. Biol. Chem. 277 (2002) 43309–43318.

    PubMed  Article  CAS  Google Scholar 

  28. Kraft, C.S., LeMoine, C.M.R., Lyons, C.N., Michaud, D., Mueller, C.R. and Moyes, C.D. Control of mitochondrial biogenesis during myogenesis. Am. J. Physiol. Cell Physiol. 290 (2006) 1119–1127.

    Article  Google Scholar 

  29. Handschin, C and Spiegelman, B.M. Peroxisome proliferator-activated receptor-γ coactivator 1 coactivators, energy homeostasis and metabolism. Endocr. Rev. 27 (2006) 728–735.

    PubMed  CAS  Google Scholar 

  30. Chang, J.H., Lin, H.K., Chung, H.S., Chang, Y.J., Chi, H.C. and Chen, S.L. Myogenic bHLH proteins regulate the expression of PPARγ coactivator-1α. Endocrinology 147 (2006) 3093–3106.

    PubMed  Article  CAS  Google Scholar 

  31. Andersson, U. and Scarpulla, R.C. Pgc-1-related coactivator, a novel serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells, Mol. Cell Biol. 21 (2001) 3738–3749.

    PubMed  Article  CAS  Google Scholar 

  32. Ventura-Clapier, R., Kaasik, A. and Veksler, V. Structural and functional adaptations of striated muscles to CK deficiency. Mol. Cell Biochem. 256/257 (2004) 29–41.

    Article  CAS  Google Scholar 

  33. de Groof, A.J.C., Oerlemans, F., Jost, C.R. and Wieringa, B. Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles. Muscle Nerve 24 (2001) 1188–1196.

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soumen Bera.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bera, S., Ray, M. The transcriptional cascade associated with creatine kinase down-regulation and mitochondrial biogenesis in mice sarcoma. Cell Mol Biol Lett 14, 481–496 (2009). https://doi.org/10.2478/s11658-009-0014-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11658-009-0014-4

Key words

  • Sarcoma
  • Creatine kinase
  • Nitric oxide synthase
  • Muscle degeneration
  • Mitochondrial biogenesis